danimer scientific, producer of biopolymers in bainbridge, ga – manufactures pha bioplastics from renewable, natural resources. danimer plastics are 100% biodegradable and compostable, and equal or exceed petroleum-based plastic commodities for price and performance. danimer, formerly mhg (meredian holdings group), along with agrocrush, create bioplastic feedstock from cold pressed canola oil, enabling global brand owners to utilize environmentally responsible materials in products that consumers purchase every day. danimer makes commercial grade pha using world-class production systems, offering a scalable, durable, and cost effective material that reduces manufacturing dependence on non-renewable, diminishing resources. danimer also offers specialty toll manufacturing at their facility. danimer provides their state of the art production equipment, laboratories, material handling and logistics, as well as their fully trained and experienced staff to other companies.. danimer uses the
Company profile
Ticker
DNMR
Exchange
Website
CEO
Richard J. Hendrix
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
DuPont de Nemours • Eastman Chemical • Dow • Albemarle • Hexion • Avient • Trinseo • Hexcel • Kraton • AdvanSix ...
Former names
Live Oak Acquisition Corp
SEC CIK
Corporate docs
Subsidiaries
Meredian Holdings Group, Inc. • Danimer Scientific Holdings, LLC • Danimer Scientific Manufacturing Inc. • Meredian, Inc. • Danimer Scientific L.L.C. • Danimer Scientific Kentucky, Inc. • Novomer, Inc. • Meredian Bioplastics, Inc. • Danimer Bioplastics, Inc. ...
IRS number
841924518
DNMR stock data
Latest filings (excl ownership)
424B3
Prospectus supplement
1 Apr 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
28 Mar 24
8-K
Danimer Scientific Announces $15 Million Registered Direct Offering
25 Mar 24
424B5
Prospectus supplement for primary offering
22 Mar 24
424B5
Prospectus supplement for primary offering
21 Mar 24
8-K
Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2023 Results
20 Mar 24
424B3
Prospectus supplement
30 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Jan 24
424B3
Prospectus supplement
18 Jan 24
Transcripts
DNMR
Earnings call transcript
2023 Q4
28 Mar 24
DNMR
Earnings call transcript
2023 Q3
14 Nov 23
DNMR
Earnings call transcript
2023 Q2
8 Aug 23
DNMR
Earnings call transcript
2023 Q1
10 May 23
DNMR
Earnings call transcript
2022 Q4
28 Mar 23
DNMR
Earnings call transcript
2022 Q3
9 Nov 22
DNMR
Earnings call transcript
2022 Q2
10 Aug 22
DNMR
Earnings call transcript
2022 Q1
11 May 22
DNMR
Earnings call transcript
2021 Q4
1 Mar 22
DNMR
Earnings call transcript
2021 Q3
16 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 91.85 mm | 91.85 mm | 91.85 mm | 91.85 mm | 91.85 mm | 91.85 mm |
Cash burn (monthly) | 4.46 mm | 744.67 k | 13.23 mm | 12.12 mm | 3.39 mm | 2.97 mm |
Cash used (since last report) | 29.77 mm | 4.97 mm | 88.29 mm | 80.88 mm | 22.64 mm | 19.79 mm |
Cash remaining | 62.08 mm | 86.88 mm | 3.57 mm | 10.98 mm | 69.21 mm | 72.07 mm |
Runway (months of cash) | 13.9 | 116.7 | 0.3 | 0.9 | 20.4 | 24.3 |
Institutional ownership, Q3 2023
34.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 150 |
Opened positions | 18 |
Closed positions | 16 |
Increased positions | 32 |
Reduced positions | 41 |
13F shares | Current |
---|---|
Total value | 80.72 bn |
Total shares | 39.64 mm |
Total puts | 1.47 mm |
Total calls | 2.09 mm |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 5.85 mm | $12.10 bn |
Vanguard | 5.02 mm | $10.40 bn |
Teramo Advisors | 3.57 mm | $7.38 bn |
Greenlight Capital | 2.60 mm | $5.39 bn |
IVZ Invesco | 2.01 mm | $4.17 bn |
STT State Street | 1.85 mm | $3.84 bn |
Geode Capital Management | 1.81 mm | $3.75 bn |
JEF Jefferies Financial | 1.55 mm | $3.21 bn |
BMO Bank of Montreal | 1.38 mm | $2.85 bn |
Marshall Wace | 1.37 mm | $2.83 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | Richard N. Altice | RSU Common Stock | Grant | Acquire A | No | No | 0 | 8,242 | 0.00 | 8,242 |
3 Apr 24 | Trump Phillip D Van | Performance Stock Award Common Stock | Grant | Acquire A | No | No | 0 | 151,585 | 0.00 | 151,585 |
3 Apr 24 | Trump Phillip D Van | Stock Appreciation Rights Common Stock | Grant | Acquire A | No | No | 1.06 | 263,410 | 279.21 k | 263,410 |
3 Apr 24 | Scott Tuten | Performance Stock Award Common Stock | Grant | Acquire A | No | No | 0 | 151,585 | 0.00 | 151,585 |
3 Apr 24 | Scott Tuten | Stock Appreciation Rights Common Stock | Grant | Acquire A | No | No | 1.06 | 263,410 | 279.21 k | 263,410 |
3 Apr 24 | Michael Eric Smith | Performance Stock Award Common Stock | Grant | Acquire A | No | No | 0 | 151,585 | 0.00 | 151,585 |
3 Apr 24 | Michael Eric Smith | Stock Appreciation Rights Common Stock | Grant | Acquire A | No | No | 1.06 | 263,410 | 279.21 k | 263,410 |
News
Piper Sandler Downgrades Danimer Scientific to Neutral, Lowers Price Target to $1.25
9 Apr 24
TD Cowen Maintains Buy on Danimer Scientific, Lowers Price Target to $2
4 Apr 24
Earnings Scheduled For March 28, 2024
28 Mar 24
Preview: Danimer Scientific's Earnings
27 Mar 24
Reported Earlier, Danimer Scientific Announced $15M Registered Direct Offering
21 Mar 24
Press releases
Danimer Scientific Announces Closing of $15 Million Registered Direct Offering
25 Mar 24
Danimer Scientific Announces $15 Million Registered Direct Offering
20 Mar 24
Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2023 Results
20 Mar 24
Danimer Scientific Announces Successful Expansion of Rinnovo® Demonstration Plant Capacity
22 Feb 24
Danimer Scientific Receives Continued Listing Standard Notice from NYSE
29 Jan 24